Singapore markets closed

Teladoc Health, Inc. (TDOC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
31.76+1.45 (+4.78%)
At close: 04:00PM EST
31.66 -0.10 (-0.31%)
Pre-market: 07:00AM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 5.38B
Enterprise value 6.06B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)2.30
Price/book (mrq)0.89
Enterprise value/revenue 2.61
Enterprise value/EBITDA -0.63

Trading information

Stock price history

Beta (5Y monthly) 1.03
52-week change 3-58.15%
S&P500 52-week change 3-9.23%
52-week high 379.90
52-week low 321.60
50-day moving average 326.69
200-day moving average 331.58

Share statistics

Avg vol (3-month) 34.43M
Avg vol (10-day) 34.34M
Shares outstanding 5161.93M
Implied shares outstanding 6N/A
Float 8160.84M
% held by insiders 10.98%
% held by institutions 182.27%
Shares short (12 Jan 2023) 429.66M
Short ratio (12 Jan 2023) 46.75
Short % of float (12 Jan 2023) 420.88%
Short % of shares outstanding (12 Jan 2023) 418.32%
Shares short (prior month 14 Dec 2022) 428.94M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-9.98%

Management effectiveness

Return on assets (ttm)-1.13%
Return on equity (ttm)-89.48%

Income statement

Revenue (ttm)2.32B
Revenue per share (ttm)14.44
Quarterly revenue growth (yoy)17.20%
Gross profit (ttm)1.38B
EBITDA 3.8M
Net income avi to common (ttm)-9.86B
Diluted EPS (ttm)-43.42
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)899.63M
Total cash per share (mrq)5.56
Total debt (mrq)1.61B
Total debt/equity (mrq)26.54
Current ratio (mrq)3.13
Book value per share (mrq)37.32

Cash flow statement

Operating cash flow (ttm)206.95M
Levered free cash flow (ttm)224.25M